Promega responds alleging invalidity of PCR patents. Roche files second series of complaints against Promega, alleging infringement of PCR patents. Promega publicly discloses data on invalidity of Taq patent. Promega files motion for Summary Judgment on invalidity of Taq patent based on prior art. Promega challenges validity of Taq patent.
Court grants Promega motion for change of venue to California.
Promega replies denying breach of contract, seeks change of venue to California.